Ian Hann
Overview
Explore the profile of Ian Hann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
780
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roberts I, Hann I
Br J Haematol
. 2020 Nov;
191(4):593-603.
PMID: 33190251
Paediatric haematology began to establish itself as a speciality in the UK just over 60 years ago. In that time, clinical trials involving all the specialist centres in the country,...
2.
3.
Thompson P, Wade R, Richards S, Gibson B, Hann I, Eden T, et al.
Br J Haematol
. 2011 Feb;
153(1):131-3.
PMID: 21275963
No abstract available.
4.
Mann G, Attarbaschi A, Schrappe M, De Lorenzo P, Peters C, Hann I, et al.
Blood
. 2010 Jul;
116(15):2644-50.
PMID: 20592248
To define a role for hematopoietic stem cell transplantation (HSCT) in infants with acute lymphoblastic leukemia and rearrangements of the mixed-lineage-leukemia gene (MLL(+)), we compared the outcome of MLL(+) patients...
5.
Harrison C, Hills R, Moorman A, Grimwade D, Hann I, Webb D, et al.
J Clin Oncol
. 2010 May;
28(16):2674-81.
PMID: 20439644
Purpose: Karyotype is an independent indicator of prognosis in acute myeloid leukemia (AML) that is widely applied to risk-adapted therapy. Because AML is rare in children, the true prognostic significance...
6.
van der Linden M, Valsecchi M, De Lorenzo P, Moricke A, Janka G, Leblanc T, et al.
Blood
. 2009 Aug;
114(18):3764-8.
PMID: 19657114
Acute lymphoblastic leukemia (ALL) diagnosed in the first month of life (congenital ALL) is very rare. Although congenital ALL is often assumed to be fatal, no studies have been published...
7.
Lonnerholm G, Valsecchi M, De Lorenzo P, Schrappe M, Hovi L, Campbell M, et al.
Pediatr Blood Cancer
. 2009 Jan;
52(5):596-601.
PMID: 19132729
Background: Interfant-99 was an international collaborative treatment protocol for infants with acute lymphoblastic leukemia (ALL). Procedure: We collected data on 103 infants at the time of their first treatment with...
8.
Pieters R, Schrappe M, De Lorenzo P, Hann I, De Rossi G, Felice M, et al.
Lancet
. 2007 Jul;
370(9583):240-250.
PMID: 17658395
Background: Acute lymphoblastic leukaemia in infants younger than 1 year is rare, and infants with the disease have worse outcomes than do older children. We initiated an international study to...
9.
Messahel B, Taj M, Hobson R, Hadzic N, Ramsay A, Hann I, et al.
Leuk Lymphoma
. 2006 Dec;
47(12):2584-9.
PMID: 17169802
Survival in childhood lymphoproliferative disease (LPD) remains poor, particularly in non-transplant patients. The anti-CD20 antibody rituximab shows promise but data in children is scant. A retrospective study of 22 (aged...
10.
Burnett A, Wheatley K, Goldstone A, Stevens R, Hann I, Hills R
Clin Adv Hematol Oncol
. 2006 Sep;
4(6):445-51.
PMID: 16981667
No abstract available.